Skip to main content
. 2023 Feb 7;24(4):3259. doi: 10.3390/ijms24043259

Table 2.

Electrophysiological features of the endothelial ICRAC.

Endothelial Cell Type ICRAC: Electrophysiological and Pharmacological Features Agonist Used to Reduce the [Ca2+]ER Intracellular Ca2+ Buffering Reference
CPAE cells IR, Erev > +40 mV, depotentiation of the Na+ currents under DVF conditions, inhibited by 10 µM La3+ Intracellular InsP3 12 mM BAPTA [35]
HUVECs, hPAECs IR, Erev > +40 mV, depotentiation of the Na+ currents under DVF conditions, inhibited by 10 µM Gd3+, activated by 5 µM 2-APB Intracellular dialysis with BAPTA or extracellular thapsigargin 20 mM BAPTA or [Ca2+]i buffered at 98 nm/L for thapsigargin-evoked currents [38]

Abbreviations: 2-APB: 2-Aminoethoxydiphenyl borate; CPAE cells: calf pulmonary artery endothelial cells; DVF: divalent-free; IR: inward rectification; Erev: reversal potential; hPAECs: human pulmonary artery endothelial cells; HUVECs: human umbilical vein endothelial cells.